A restatement is the one filing where the past moves. $DVLT -16.79% after the close on an 8-K Item 4.02, non-reliance on previously issued financial statements. Our feed carries the item code; it does not carry the periods or the size of the correction.
Put it next to #CTOR, which filed Item 2.02 results today and is down 10.19%. Citius Oncology handed the market new numbers, and the argument is about whether they are good. Datavault AI took numbers back, and the argument is about which ones, an argument nobody outside the building can have until the exhibit says.
That gap is the whole trade. A miss has a size at 4:01 PM. A non-reliance notice has a size too, but tonight it is a blank, and 971 million shares of float are being repriced against a blank on a $146 million market cap. Every valuation built on the old filings is now resting on numbers the company itself won't stand behind, and the sellers in the first minute didn't know by how much either.
There is no sample for this name worth quoting, and I'm not borrowing a cross-stock gap rate to dress up a filing that hasn't disclosed its own damage. Go make dinner. The exhibit will eventually state the number; your stop won't.